N-Acetylglucosamine-6-phosphate deacetylase (NagA) and glucosamine-6-phosphate deaminase (NagB) are branch point enzymes that direct amino sugars into different pathways. For Staphylococcus aureus NagA, analytical ultracentrifugation and small-angle X-ray scattering data demonstrate that it is an asymmetric dimer in solution. Initial rate experiments show hysteresis, which may be related to pathway regulation, and kinetic parameters similar to other bacterial isozymes. The enzyme binds two Zn 2+ ions and is not substrate inhibited, unlike the Escherichia coli isozyme. S. aureus NagB adopts a novel dimeric structure in solution and shows kinetic parameters comparable to other Gram-positive isozymes. In summary, these functional data and solution structures are of use for understanding amino sugar metabolism in S. aureus, and will inform the design of inhibitory molecules.
The catabolism and biosynthesis of amino sugars must be regulated to prevent futile cycling of metabolites. Glutamine-fructose-6-phosphate aminotransferase (GlmS, EC 2.6.1.16) catalyses the reverse reaction of NagB, providing the link from central carbon metabolism to peptidoglycan biosynthesis. Regulation of the nagA, nagB and glmS genes is one mechanism through which amino sugar catabolism and synthesis can be coordinated. In Escherichia coli, the divergent nag-BACD and nagE operons are repressed by a regulatory protein, NagC, which also activates the glmUS operon, encoding biosynthetic enzymes [7] . The inducer molecule for NagC is N-acetylglucosamine-6-phosphate (GlcNAc6P). Furthermore, GlcNAc6P acts a regulator at an enzymatic level, allosterically activating E. coli NagB, in what is hypothesised to be a feed-forward mechanism of sensing flux [8] .
We note that in S. aureus USA_300 TCH1516, the nagA and nagB genes are not organised in a canonical operon. Instead, they are distant from one another in the genome, similar to nagA and nagB in Vibrio species [9] . As such it is has not been determined how NagC regulates nagA and nagB in S. aureus. Instead, the only layer of regulation that has been detailed is control of GlmS expression by the glmS ribozyme, which is activated by glucosamine-6-phosphate [10] . Fig. 1 . Amino sugar uptake and utilisation pathway in Staphylococcus aureus. We focus on the enzymes NagA and NagB, which catalyse the reactions highlighted in the orange box. Green illustrates the sialic acid degradative enzymes [35] [36] [37] . Purple shows the recently identified proteins of the peptidoglycan recycling pathway in S. aureus [38] . This proposed pathway is based on those established in Escherichia coli and Bacillus subtilis [39] , and S. aureus [11] , as well as curated KEGG genome data [40] . For clarity, the substrate and enzyme names are abbreviated.
Thus, it remains unclear how S. aureus NagA and NagB are regulated at both the genetic and enzymatic levels to respond to the metabolic needs of the cell.
Targeting the enzymes responsible for maintaining the intracellular pool of glucosamine-6-phosphate (used for cell wall biosynthesis) may have therapeutic utility for treating microbial infection. S. aureus growth is inhibited by disrupting either the uptake or catabolism [11] , or the de novo biosynthesis of the cell wall precursor glucosamine-6-phosphate [10, 12] . This inhibition probably results from the disruption of cell wall biosynthesis. Further, when grown on amino sugars, knocking out nagA or nagB increases the susceptibility of S. aureus to b-lactams [11] . Presumably, disruption of the pathway hampers cell wall biosynthesis, leading to diminished growth and vulnerability to antimicrobial agents.
Here, we report the kinetic and solution structure properties of NagA and NagB from S. aureus, which provide data key to understanding how these reactions are catalysed and regulated in S. aureus, and also provide a first step towards the rational design of new enzyme inhibitors to address the ongoing problem of antimicrobial resistance.
Materials and methods

Bioinformatics
Theoretical molecular weights, extinction coefficients and isoelectric points were computed using the ExPASy ProtParam tool [13] . To search and compare protein and nucleotide sequences, the basic local alignment search tool (BLAST) programs BLASTN and BLASTP were used. Multiple sequence alignments were generated using CLUSTAL OMEGA [14] , and prepared using ESPript 3.0 [15] . Amino acid sequences for isozymes were sourced from the NCBI database.
Cloning
The nagA gene encoding NagA and the nagB gene encoding NagB from S. aureus subsp. aureus USA300_TCH1516 (GenBank accession: CP000730.1) were synthesised commercially by Genscript with NdeI (5 0 ) and HindIII (3 0 ) restriction enzyme sites. Both genes were cloned into the pET30DSE expression vector [16] by digestion with NdeI and HindIII restriction enzymes, purified using an agarose gel DNA extraction kit (Roche) and ligated with T4 DNA ligase (Takara) at 293 K for 50 min to create pET30DSE/ nagA and pET30DSE/nagB respectively. These restriction sites were chosen to give an insert without purification tags. These plasmids were transformed into XL1-Blue Competent Cells (Agilent), purified using the DNA-Spin TM Plasmid DNA Purification Kit (iNtRon Biotechnology), and verified by DNA sequencing (Macrogen).
Protein expression and purification
The pET30DSE/nagA and pET30DSE/nagB plasmids were transformed into E. coli BL21(DE3) competent cells (Agilent) and grown at 37°C with shaking at 200 r.p.m. in Luria-Bertani media supplemented with kanamycin (30 lgÁmL
À1
) until an OD 600 of 0.4-0.6 was reached. Protein expression was induced with isopropyl b-D-1-thiogalactopyranoside to a final concentration of 1 mM, followed by further incubation at 26°C with shaking at 200 r.p.m. overnight. For overexpression of NagA, ZnCl 2 was also added to a final concentration of 1 mM. Cells were harvested by centrifugation using a Thermo Sorvall RC-6 Plus centrifuge for 10 min, at 6250 g and 4°C. Cells were resuspended in 20 mM Tris/ HCl, 0.1 mM phenylmethylsulfonyl fluoride, pH 8.0, and lysed by sonication using a Hielscher UP200S Ultrasonic Processor at 70% amplitude in cycles of 0.5 s on, 0.5 s off, for 15 min. Cell debris was pelleted by centrifugation at 24 000 g, for 15 min, at 4°C.
Clarified lysate was first purified by anion-exchange chromatography and loaded onto a Q sepharose column (GE Healthcare), equilibrated with five column volumes of 20 mM Tris/HCl, pH 8.0. The column was then washed with 3-5 column volumes of 20 mM Tris/HCl, pH 8.0 to remove any unbound material, until a baseline absorbance at 280 nm was reached. Bound protein was eluted using a continuous gradient of 20 mM Tris/HCl, 1 M NaCl, pH 8.0, over 3-4 column volumes. Hydrophobic-interaction chromatography was implemented as the second purification step. Ammonium sulfate was added to the protein pooled from the anion-exchange step to a final concentration of 1 M. A HiPrep Phenyl column (GE Healthcare) was equilibrated with five column volumes of 20 mM Tris/HCl, 1 M (NH 4 ) 2 SO 4 , pH 8.0, prior to sample loading. The column was washed with this buffer until a steady baseline absorbance at 280 nm was reached. Sample was eluted from the column using a continuous gradient 20 mM Tris/HCl, pH 8.0, over four column volumes.
Size-exclusion chromatography was used as a final polishing step for the purification of both NagA and NagB proteins. A HiLoad Superdex 200 16/60 120 mL column (GE Healthcare) was equilibrated with three column volumes of 20 mM Tris/HCl (SEC buffer), pH 8.0. Pooled fractions from the previous purification step were concentrated to approximately 1% of the column volume (up to 50 mgÁmL À1 ) using spin concentrators with an appropriate size molecular weight cutoff, either 30 kDa for NagA, or 10 kDa for NagB (Sartorius). At each purification step, eluted fractions corresponding to 280 nm absorbance peaks were analysed by SDS/PAGE for the protein of interest before being pooled. Following size-exclusion chromatography, any protein that was not immediately used in experiments was flash frozen in liquid nitrogen and stored at À80°C, at 2 mgÁmL À1 in SEC buffer.
Enzyme kinetics
Kinetics experiments were carried out on a Cary 100 Bio UV/Vis spectrophotometer (Agilent Technologies). Enzyme assays were performed in triplicate, and the initial velocity measurements were reproducible to within 10% error. All enzymes and substrate stocks were kept on ice throughout the duration of the assays, with reaction mixtures allowed to equilibrate for 20 min in the heatcontrolled Peltier module prior to measurement. NagA was assayed at 30°C degrees to allow direct comparison to the results of the original assay [17, 18] , while NagB was assayed at 20°C due to the low thermostability of the coupling enzymes used. Substrates and buffers were prepared on the day of the assay. N-Acetylglucosamine-6-phosphate and glucosamine-6-phosphate were purchased from Carbosynth. Chemicals used were sourced from Invitrogen and Sigma-Aldrich, unless explicitly stated. Phosphoglucoisomerase from Saccharomyces cerevisiae and glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides were purchased from SigmaAldrich.
NagA direct continuous assay
Kinetic analysis of NagA was performed using a previously described direct continuous spectrophotometric assay [19] . Here, the rate of reaction was measured by following the decrease in UV absorbance at 215 nm of the carboxamido group of N-acetylglucosamine-6-phosphate, as a function of time. The assay was performed in quartz cuvettes with a path length of 10 mm. An extinction coefficient of 247 M
À1
Ácm
À1
for GlcNAc6P was determined spectrophotometrically.
The assay mixture (20 mM Tris/HCl pH 8.0, and substrate varied from 0.1 to 2 mM) was equilibrated at 30°C in the spectrophotometer's Peltier module for 20 min. The pH was checked after equilibration using a micro-pH meter. Enzyme fresh from purification was kept on ice and the reaction initiated by the addition of 20 lL (into 480 lL assay mixture), giving a final concentration of 25 nM (1.1 lgÁmL À1 ). For the data collected at varying substrate concentrations (Fig. 4C) , the assay was not further supplemented with ZnCl 2 , which was added to the growth media (1 mM) and co-purified with the enzyme. For the data collected at varying ZnCl 2 concentrations, the enzyme preparation was first dialysed over 3 days against a 1000-fold volume excess of Tris/HCl (pH 8.0, 20 mM) with ethylenediaminetetraacetic acid (EDTA) (60 mM) at 4°C, which abolished all enzymatic activity. The EDTA was then removed by dialysis against a 1000-fold volume excess of Tris/HCl (pH 8.0, 20 mM) three times, followed by running the protein through a HiTrap desalting column (GE Healthcare) twice. The Nacetylglucosamine-6-phosphate concentration was held at 1 mM and the final protein concentration was 100 nM. Initial rate data were analysed and fitted with the substrate inhibition model using GRAPHPAD PRISM 7.0 software (GraphPad Software, La Jolla California USA, www.graphpad.com).
NagB coupled-coupled assay
Kinetic analysis of NagB was performed using a coupledcoupled assay, as described by Vincent et al. [20] . The reaction was observed by measuring the increase in UV absorbance at 340 nm due to the consumption of NADP + . The reaction was performed in acrylic cuvettes with a 10 mm path length. Reaction mixtures were allowed to equilibrate at 20°C for 20 min in the heat-controlled Peltier module. Controls were performed to ensure that both the enzyme concentration was within the linear range, and that each coupling enzyme was in excess.
The reaction was initiated by the addition of 20 lL of NagB to give a final concentration of 0.3 lgÁmL phosphoglucoisomerase and 50 lgÁmL À1 glucose-6-phosphate dehydrogenase. Phosphoglucoisomerase was supplied as an ammonium sulfate suspension. To prevent any interference in the NagB catalysed reaction by ammonium ions, the enzyme was pelleted by centrifugation at 15 000 g for 20 min at 4°C, and then resuspended in 20 mM Tris/HCl. This process was then repeated to ensure thorough removal. Glucose-6-phosphate dehydrogenase was supplied as a lyophilised powder, and was made up using 20 mM Tris/HCl.
Analytical ultracentrifugation
Sedimentation velocity experiments were performed using an XL-I analytical ultracentrifuge (Beckman Coulter). The protein samples were buffer exchanged into 20 mM Tris/HCl, 150 mM NaCl, pH 8.0. Proteins were centrifuged at 50 000 r.p.m. at 20°C. Radial absorbance data were collected at 280 nm without averaging for a total of 125 scans. Reference (400 lL) and sample (380 lL) solutions were loaded into 12 mm double sector cells with sapphire windows, and then mounted into an An-60 Ti four-hole rotor (Beckman Coulter). Solvent viscosity and density, as well as estimates of the partial specific volume were calculated using the program SED-NTERP [21] . Sedimentation data were fitted using either a continuous size distribution [c(s)] sedimentation coefficient model or a continuous mass distribution [c(M)] model using the program SEDFIT [22] .
Size-exclusion chromatography coupled with multi-angle laser light scattering SEC-MALLS experiments were carried out using a Viscotek 302-040 Triple Detector GPC/SEC system (ATA Scientific), operated at 28°C. Protein sample (100 lL) at 2.1 mgÁmL À1 was injected onto a 24 mL Superdex200 10/ 300 size-exclusion column, equilibrated with SEC buffer. Measurements were calibrated against BSA standard at 4 mgÁmL À1 . Baseline fitting, integration limit fitting and the mass calculations were all performed using OMNISEC software (Malvern Panalytical).
Small-angle X-ray scattering
Scattering data were collected at the SAXS/WAXS beamline (Australian Synchrotron) equipped with a Pilatus 1M detector (170 mm 9 170 mm effective pixel size).
The wavelength of the X-rays was 1.0332 A. A sampledetector distance of 1600 mm was used. For both proteins analysed, 50 lL of sample at 6 mgÁmL À1 were loaded onto an in-line Superdex 200 5/150 GL size-exclusion column (GE Healthcare), pre-equilibrated with 20 mM Tris/HCl, 150 mM NaCl, pH 8.0. Two-dimensional intensity plots were radially averaged, normalised to sample transmission, and background subtracted using the SCATTERBRAIN software package (Australian Synchrotron). Analysis of the data was performed using the ATSAS software package (version 2.8.0) [23] . PRIMUSQT [23] was used to perform the Guinier analyses and the indirect Fourier transform of the data to give the P(r) distribution. CRYSOL [23] was used to calculate theoretical scattering from atomic coordinates and compare them to the experimental scattering curves.
Results and Discussion
Purification of NagA and NagB Recombinantly expressed S. aureus NagA and NagB were purified to near homogeneity using anionexchange, hydrophobic-interaction and size-exclusion chromatography ( Fig. 2A) .
SDS/PAGE of purified NagB suggests that a small proportion of disulfide-bonded dimer exists (Fig. 2B) . Under reducing conditions with 1 mM tris(2-carboxyethyl)phosphine (TCEP), only a single band is present. However, running the same sample under non-reducing conditions, two bands are apparent, one corresponding to the monomeric molecular mass of 28.5 kDa, and the second consistent with the molecular mass of a 57 kDa dimeric species. This suggests that a small proportion of S. aureus NagB is dimeric, stabilised by one or more disulfide bonds.
Altamirano et al. [24] demonstrated using similar reducing/non-reducing SDS/PAGE experiments that the E. coli NagB isozyme can form interchain disulfides, via Cys-219 (numbered according to the E. coli NagB sequence). There are three cysteines in the S. aureus NagB amino acid sequence (Cys-18, Cys-30, and Cys-239 numbered according to S. aureus, Fig. S1 ). To map these residues, we generated a homology model of S. aureus NagB using RaptorX [25] . This shows that none of the three cysteines in S. aureus NagB are in an equivalent position to E. coli Cys-219, but they may be surface accessible for disulfide bonding (Fig. S2) . Whether or not an S. aureus disulfide-bonded dimer is biologically relevant is unknown. For E. coli NagB, which forms a hexamer in solution, and in crystal form (PDB id: 1HOR), it has been demonstrated that intersubunit disulfides do not contribute to the overall hexameric structure, stability or kinetics of the enzyme [24] .
The solution structure of NagA
The potential for a change in multimeric state as a mechanism for regulating NagA activity led us to evaluate the oligomeric state of S. aureus NagA. While E. coli NagA is a tetramer in solution and in crystal form (PDB id: 1YRR) [26] , the Bacillus subtilis [27] and Mycobacterium smegmatis [28] (Fig. 3B) confirm that the major species in solution has a molecular mass of 86.8 kDa, also consistent with the mass of a dimer. Small-angle X-ray scattering data are consistent with a dimeric NagA organisation (Fig. 3C , SASBDB accession code: SASDEA6). CRYSOL [23] was used to calculate and fit a theoretical solution scattering curve for the B. subtilis dimer and the E. coli tetramer to the solution scattering profile of S. aureus NagA. As shown in Fig. 3C , this theoretical scattering curve for the B. subtilis dimer fitted the data well, giving a reduced v 2 value of 0.18, suggesting B. subtilis NagA and S. aureus NagA share a very similar global architecture. S. aureus NagA shares 44% sequence identity (98.5% coverage) with the B. subtilis isozyme (determined using CLUSTAL OMEGA [14] ). Guinier analysis using PRIMUS [23] gave a forward scattering value (I 0 ) of 0.068, and a radius of gyration (R g ) of 31.6 A (Table 1) , in agreement with the R g calculated using GNOM [23] (31.9 A). The maximum distance (D max ) of NagA was determined to be 101
A from the P(r) analysis (Fig. 3D) . The diameter of the B. subtilis dimer envelope calculated by CRYSOL is 100
A. Overall, the solution structure of S. aureus NagA is dimeric and is likely to be similar in architecture to that of the B. subtilis isozyme, with each subunit protruding into the adjacent subunit's active site [27] . This architecture is also seen in the recently detailed M. smegmatis NagA dimer [28] .
Functional characterisation of NagA
Initial rate experiments were undertaken to determine the kinetic properties of S. aureus NagA, examine its requirement for metal cofactors and determine whether the enzyme is regulated. Initial rate data were collected using a direct continuous assay that monitors the rate of N-acetylglucosamine-6-phosphate deacetylation by following the decrease in absorbance at 215 nm (the carboxamido group of N-acetylglucosamine-6-phosphate absorbs at 215 nm) [19] . A range of NagA isozymes require divalent metal cations for function [17] [18] [19] [26] [27] [28] , binding either one or two metal ions in the active site. The kinetic studies presented here used enzyme preparations that had ZnCl 2 (1 mM) in the growth media, a strategy used by others for NagA expression [18] . The initial rate measured for NagA has a significant substrate concentration-dependent lag phase (Fig. 4A) . As shown in Fig. 4B , this lag is prominent at substrate concentrations greater than 0.5 mM. The increase in initial rate over time suggests that the enzyme may be slowly activated by either the substrate or product, a phenomenon known as hysteresis [29] . The lag occurs when the reaction is initiated with either enzyme or with substrate. Temperature equilibration of both the assay mixture and the initiating enzyme has no effect on this observed lag. The lag phase was not found to be pH dependent across a pH range of 7.5-8.5. Addition of ZnCl 2 to the assay mixture had no effect on the observed lag phase (Fig. S4) . This behaviour was not reported for the E. coli [19] or Thermotoga maritima [18] isozymes using the same assay.
Hysteretic responses may be attributed to various oligomeric states that have different activities [30] , or caused by slow conformational changes where conformers have different kinetic properties [29] .
As demonstrated here, S. aureus NagA is a dimer in solution resembling the B. subtilis and M. smegmatis dimeric arrangement. This was established by measurements made in the low lM enzyme concentration range (7.0 lM), 280-fold greater than enzyme concentrations used in the assay (0.025 lM). It is possible that at these concentrations a small proportion of S. aureus NagA exists as a monomer, and that both the monomer and the dimer each have different kinetic properties. This is supported by the crystal structure of B. subtilis NagA, which shows that residues His-233 and Arg-234 form a 'pincer-like' extension from the b 6 a 6 loop of each subunit and protrude into the active site of the opposite monomer where they bind the phosphate moiety of the substrate [27] . The involvement of both subunits in binding substrate gives rise to the potential for ligand-induced dimerisation, and for a monomer and dimer to each have different kinetic properties. Both residues are present in the S. aureus NagA sequence at equivalent positions (His-236 and Arg-237) (Fig. S3) . Ligand-induced dimerisation also fits with the observation that the lag increases with substrate concentration (Fig. 4B ).
An alternative explanation for the observed lag phase is that the dimer undergoes a slow conformational change to a conformer with different kinetic properties. In the M. smegmatis NagA crystal structure co-crystallised with substrate (PDB id: 6FV4), there is density for substrate in only one of the two active sites within the dimer. The active site without substrate is occluded by a loop [28] , which would have . The Guinier plot shows linearity at low q angles, indicating that scattering was not effected by either aggregation or interparticle interference. (D) P(r) plot estimating a maximum pair-wise distance of~101 A.
to move to provide a fully active enzyme (i.e. both active sites available for catalysis).
Hysteresis is thought to play a role in regulating metabolism [30] . In this context, a lag could cause a time-dependent buffering of metabolite flux, which may well be important in pathways that utilise common intermediates, or where there are multiple branch points. NagA catalyses the formation of glucosamine-6-phosphate, a common intermediate that is either fed into peptidoglycan biosynthesis or glycolysis. A lag phase could be part of a mechanism that buffers against rapid flux from multiple pathways feeding into NagA. However, the relevance of a lag phase in vivo is uncertain, as intracellular N-acetylglucosamine-6-phosphate concentrations in S. aureus are unknown.
We next determined the kinetic parameters of the enzyme and investigated the metal ion requirements for catalysis. To collect initial rate data, the steepest portion of the reaction curve was used, immediately following the initial lag phase. The data were well described by the classical Michaelis-Menten model (Fig. 4C) , providing a k cat = 345 AE 6 s À1 and K m = 0.16 AE 0.01 mM ( Table 2) . These parameters are similar to those reported in the literature for other isozymes (Table 2 ). In addition, the S. aureus isozyme does not show substrate inhibition, unlike E. coli NagA, where Souza et al. [19] report that the enzyme is inhibited by both the substrate and product.
To test whether the presence of a metal ion is essential for activity, metal ion titration experiments were conducted, based on those performed by Ferreira et al. [26] . S. aureus NagA was dialysed against a 1000-fold volume excess of Tris/HCl (20 mM) with EDTA (60 mM), pH 8.0, at 4°C, which abolished all enzymatic activity. Reconstitution of metal ions was performed by titrating in metal salts to the already treated apoenzyme. Zn 2+ was tested as it was observed in the E. coli NagA active site (PDB id: 2p50) and Fe 2+ was tested as it was observed in the B. subtilis NagA active site (PDB id: 2VHL). Addition of FeSO 4 did not restore activity, while addition of ZnCl 2 did. When monitoring specific activity as a function of ZnCl 2 concentration (Fig. 4D) , the data best fit to the Hill equation, with saturation at > 20 lM and a K 0.5 = 3.8 AE 0.2 mM, n = 2.6 AE 0.3, which extends beyond the theoretical limit of two binding sites (i.e. two active sites). Reconstitution with 20 lM ZnCl 2 fully restored activity, although not to the maximal initial velocity observed in Fig. 4C . This may be due to loss of activity during dialysis and reconstitution, and the relatively harsh treatment with EDTA (60 mM). The sigmoidal response with respect to Zn 2+ concentration suggests cooperativity and the binding of at least two metal ions within the active site. This is consistent with the binuclear B. subtilis isozyme, which shows two Fe 2+ ions bound in the active site [27] . In contrast, the E. coli and T. maritima isozymes have mononuclear metal centres [18] . Examination of the available crystal structures shows significant divergence in the active site architecture between the mononuclear (E. coli, T. maritima) and binuclear (B. subtilis, M. smegmatis) enzymes. This divergence also reflects differences in catalytic mechanisms [18] . The binuclear metal ion-binding site is attributed to a dual histidine motif (His-x-His) at the end of b-strand 1 of the B. subtilis isozyme that binds two Fe 2+ ions. A sequence alignment of various Gramnegative and Gram-positive NagA enzymes demonstrates that this motif is also present in S. aureus (Fig. S3) . However, this motif is absent in Gram-negative isozymes and replaced by a Gln-x-Asn motif (Fig. S3) . In E. coli NagA, His-143 is proposed to be diagnostic of the overall metal ligation scheme. Here, His-143 is hypothesised to help polarise the carbonyl of N-acetylglucosamine-6-phosphate during bond cleavage, presumably in lieu of a second metal ion [18] . In groups of sequences that cluster with known binuclear enzymes, a glutamine or glutamate residue is present corresponding to His-143. As shown in Fig. S3 , S. aureus NagA has a glutamine at this position.
In summary, we demonstrate that S. aureus NagA displays hysteresis, has kinetic parameters consistent with other characterised isozymes, is not inhibited by its substrate, and is a binuclear type enzyme that uses Zn 2+ .
The solution structure of NagB
As for NagA, AUC, SAXS and SEC-MALLS experiments demonstrate that S. aureus NagB is also a dimer in solution. This is in contrast to the monomeric Gram-positive Streptococcus mutans and B. subtilis isozymes. In fact, although the PDB contains a number of structures of bacterial NagB enzymes, all of the assigned biological assemblies are either monomeric [B. subtilis (PDB id: 2BKX), S. mutans (PDB id: 2RI0) and T. maritima (PDB id: 1J5X)], trimeric [Vibrio cholerae (PDB id: 5HJ5)] or hexameric [E. coli (PDB id: 1HOR) and Borrelia burgdorferi (PDB id: 3HN6)]. This is the first time a dimeric oligomeric state for a bacterial NagB has been reported. Sedimentation velocity data (collected at 0.3 mgÁmL À1 , 10.5 lM) support a dimeric conformation in solution. The data were fitted with a continuous [c(s)] distribution model, which shows the sample is monodisperse, with a single, symmetrical peak at a sedimentation coefficient of 3.75 S. A frictional ratio (f/f 0 ) of 1.46 indicates that the protein has a more extended shape in solution, as compared to S. aureus NagA (f/f 0 = 1.34). Fitting this data using a continuous mass [c(M)] distribution model (Fig. 5A) gives an apparent molecular mass of 61.8 kDa, which is close to the calculated dimer mass of 56.9 kDa based on the sequence. SEC-MALLS, at a loading concentration of 2.1 mgÁmL À1 , supports a dimer in solution with a molecular mass of 55.3 kDa (calculated dimer mass of 56.9 kDa) (Fig. 5B) . These data are also consistent with the presence of a small amount of disulfide-stabilised dimer observed using SDS/PAGE (Fig. 2B) . Small-angle X-ray scattering data (SASBDB accession code: SASDEB6) gave a predicted molecular mass of 59.8 kDa, when analysed using SAXS MOW2 [31] . Using CRYSOL, we fitted the scattering data (Fig. 5C, fit 1, blue line) to the monomeric S. mutans structure (PDB id: 2RI0), which gave a poor fit (reduced v 2 value of 114). Since there are no representative NagB dimers reported, we constructed two possible dimers of NagB from the E. coli hexamer (PDB id: 1HOR) and fitted these to the scattering data. The E. coli NagB hexamer can be considered a dimer of trimers. A dimer that was constructed from monomers within the trimer (Fig. 5C , fit 2, red line) fits the scattering data well giving a reduced v 2 value of 0.54, suggesting they share a very similar global architecture or shape. However, a dimer constructed from monomers that span the trimer interface (Fig. 5C, fit 3 , green line) has a considerably worse fit with a reduced v 2 value of 22. S. aureus NagB shares 29.2% sequence identity (99.6% coverage, using CLUSTAL OMEGA) with the E. coli isozyme. The forward scattering value (I 0 ) of 0.07 and a radius of gyration (R g ) of 27.3
A (Table 1) were calculated using PRIMUS, in agreement with the R g calculated using GNOM [23] . The maximum interatomic distance (D max ) of NagB was calculated from the P(r) plot (Fig. 5D) as 89
A. The P(r) analysis is consistent with the shape of the enzyme being closer to an ellipsoid than a sphere, and supports the observation of an extended shape as suggested by the frictional ratio determined using AUC.
Taken together, biophysical analyses demonstrate that S. aureus NagB has a novel dimeric oligomeric structure. The solution shape of S. aureus NagB is somewhat more asymmetric than that of S. aureus NagA, as judged by the frictional ratio determined using AUC. An E. coli dimer (constructed from monomers within the trimer) fits well to the small-angle scattering data, suggesting they share a similar shape. This dimer is of note, as it broadens the structural landscape of NagB enzymes, where the monomeric B. subtilis NagB was previously thought to be representative of Gram-positive NagB isozymes [20] .
Functional characterisation of NagB
A coupled-coupled assay adapted from Vincent et al. [20] was used to collect initial rate data for S. aureus NagB. A reduction in the initial velocity of the reaction is seen with increasing concentration of the substrate glucosamine-6-phosphate (Fig. 6) , consistent with the substrate inhibiting the enzyme. The biological relevance of substrate inhibition here is unclear. The data were fitted to a Michaelis-Menten equation adjusted for substrate inhibition, which gave the following parameters: k cat = 105 AE 16 s À1 , K m = 0.24 AE 0.08 mM and K i = 3 AE 1 mM (Table 2 ). Compared to values reported for other Gram-positive NagB isozymes, S. aureus NagB has a similar K m for N-acetylglucosamine-6-phosphate and a similar k cat [20, 32] , as shown in Table 2 . The k cat is slightly lower than that reported for Gram-negative isozymes, for example the E. coli isozyme ( Table 2) . Liu et al. [32] suggests that the lower activity of Gram-positive NagB isozymes compared to their Gram-negative isozymes may have evolved in response to a greater requirement for glucosamine-6-phosphate to be directed into the peptidoglycan biosynthesis pathway. However, we find that the catalytic efficiency (k cat /K m ) of Gram-positive NagB isozymes is comparable to Gram-negative NagB isozymes (Table 2) .
Staphylococcus aureus NagB is active without the need for allosteric activation. No rate increase was observed when N-acetylglucosamine-6-phosphate (the allosteric activator for E. coli NagB) was added to the assay mixture, or when incubated with the enzyme prior to adding it to the assay. This lack of allostery has also been observed in the monomeric S. mutans and B. subtilis NagB enzymes, and supports the hypothesis that Gram-positive NagB enzymes have lost the property of allosteric regulation [20] . The importance of allostery as a regulatory mechanism in amino sugar metabolism been tested in in vivo.
AlvarezAñorve et al. [8] performed E. coli growth experiments, where the gene for the allosteric E. coli NagB was replaced with the gene of the non-allosteric B. subtilis NagB. No effect on growth rates, competitive fitness or any change in concentration of central metabolites was observed with the non-allosteric B. subtilis enzyme. The physiological relevance of NagB enzymatic regulation is therefore yet to be fully understood.
Investigating the interaction between S. aureus NagA and NagB
Given that the S. aureus NagA and NagB enzymes catalyse sequential steps in a pathway and do not appear to be regulated, we tested whether they interact directly, which might allow a complex to be regulated. Here, a sedimentation velocity experiment was performed. As shown in Fig. 7 (black line), a mixture of NagA and NagB at a 1 : 1 ratio displays only a slight peak broadening to the right, extending from a value of 6 to 8 S, which is not seen when the proteins are run independently (red and blue lines). We conclude from this result that the two enzymes do not interact under the conditions of the experiment. Consistent with our result, an interaction between the B. subtilis homologues has also been probed, where no protein-protein interaction was detected [20] . One limitation is that the buffer conditions do not resemble the physiological conditions or the extremely crowded environment of a cell, where it is suggested that specific protein-protein interactions are more frequent than in in vitro experiments given the excluded volume phenomenon [33] .
Concluding remarks
NagA and NagB enzymes are the central enzymes for amino sugar metabolism in bacteria, since their activity decides between amino sugar catabolism and peptidoglycan biosynthesis. How the cell makes this decision is unclear. We have characterised these enzymes from S. aureus, a serious human bacterial pathogen. We demonstrate that S. aureus NagA requires two Zn 2+ metal ions for activity and displays an unusual hysteretic behaviour, which may have a role in regulating flux at this step. We find that S. aureus NagB has a unique dimeric architecture, in contrast to all other Gram-positive isozymes reported to date, which are monomeric and not allosterically regulated. The Gram-negative isozymes, such as E. coli NagB, have higher oligomeric states and are allosterically regulated by N-acteylglucosmine-6-phosphate. We tested whether these two enzymes interact and find no evidence to support this hypothesis.
Supporting information
Additional supporting information may be found online in the Supporting Information section at the end of the article. Fig. S1 . Sequence alignment of Staphylococcus aureus NagB with isozymes from Gram-positive (S. epidermidis to Enterococcus faecalis) and Gram-negative (V. cholerae to E. coli) bacteria using the CLUSTAL OMEGA server (https://www.ebi.ac.uk/Tools/msa/clustalo/) [34] . Fig. S2 . Homology model of NagB, based on the B. subtilis isozyme (PDB id: 2BKV), showing three surface accessible cysteines. Fig. S3 . Sequence alignment of Staphylococcus aureus NagA with isozymes from Gram-positive (S. epidermidis to M. smegmatis) and Gram-negative (H. influenzae to E. coli) bacteria using the CLUSTAL OMEGA server (https:// www.ebi.ac.uk/Tools/msa/clustalo/) [34] . Fig. S4 . Reaction curves of Staphylococcus aureus NagA demonstrating the presence of a lag phase across different temperatures and pH, and with the addition of metal ions to the assay.
